Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer pati

Autor: Palmieri, M, Baldassarri, M, Fava, F, Fabbiani, A, Gelli, E, Tita, R, Torre, P, Petrioli, R, Hadijstilianou, T, Galimberti, D, Cinotti, E, Bengala, C, Mandala', M, Piu, P, Miano, St, Martellucci, I, Vannini, A, Pinto, Am, Mencarelli, Ma, Marsili, S, Renieri, A, Frullanti, E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3982::4f3f9f52edf55448bb6401bba72173f1
http://hdl.handle.net/11391/1480822

CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab

Autor: Petrioli, Roberto, Licchetta, A, Roviello, Franco, Pascucci, A, Francini, E, Bargagli, G, Conca, R, Miano, St, Marzocca, G, Francini, Guido, Multidisciplinary Oncology Group on Gastrointestinal Tumors, Savelli, Vinno

Publikováno v: Cancer investigation. 30(1)

We evaluated the changes of the tumor markers CEA and CA19.9 as early predictors of progression in metastatic colorectal cancer (mCRC) patients participating in a clinical study and receiving chemotherapy and bevacizumab (Bev). Seventy-two patients h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d14c5fffd79d84b81eb4d4648761c32
https://pubmed.ncbi.nlm.nih.gov/22236191

Aggressive Angiomyxoma of the Lower Female Genital Tract: A Review of the MITO Rare Tumors Group.

Autor: Dellino M; Department of Interdisciplinary Medicine (DIM), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy., Magazzino F; Complex Operating Unit Ginecologia E Ostetricia, Ospedale Civile Di San Dona' Di Piave (Venezia), Aulss4 Veneto Orientale, 30027 San Donà di Piave, Italy., Domenici L; Division of Obstetrics and Gynecology, Azienda Ospedaliera Universitaria Pisana, University of Pisa, 56126 Pisa, Italy., Cicogna S; Institute for Maternal and Child Health-IRCCS 'Burlo Garofolo', 34145 Trieste, Italy., Miano ST; Complex Operating Unit of Oncology, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS 'Fondazione G Pascale', 80144 Napoli, Italy., Mangili G; Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Cormio G; Department of Interdisciplinary Medicine (DIM), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy.; Gynecologic Oncology, IRCCS Istituto Tumori 'Giovanni Paolo II', 70124 Bari, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2024 Mar 31; Vol. 16 (7). Date of Electronic Publication: 2024 Mar 31.

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study.

Autor: Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy. Electronic address: edoardo.francini@unifi.it., Ou FS; Mayo Clinic, Rochester, MN, USA., Lazzi S; Department of Human Pathology and Oncology, University of Siena, Siena, Italy., Petrioli R; Santa Maria Alle Scotte Hospital, Siena, Italy., Multari AG; Santa Maria Alle Scotte Hospital, Siena, Italy., Pesola G; Santa Maria Alle Scotte Hospital, Siena, Italy., Messuti L; Santa Maria Alle Scotte Hospital, Siena, Italy., Colombo E; Santa Maria Alle Scotte Hospital, Siena, Italy., Livellara V; Santa Maria Alle Scotte Hospital, Siena, Italy., Bazzurri S; Santa Maria Alle Scotte Hospital, Siena, Italy., Cherri S; Santa Maria Alle Scotte Hospital, Siena, Italy., Miano ST; Santa Maria Alle Scotte Hospital, Siena, Italy., Wolfe EG; Mayo Clinic, Rochester, MN, USA., Alberts SR; Mayo Clinic, Rochester, MN, USA., Hubbard JM; Mayo Clinic, Rochester, MN, USA., Yoon HH; Mayo Clinic, Rochester, MN, USA., Francini G; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy.

Publikováno v: Translational oncology [Transl Oncol] 2021 Feb; Vol. 14 (2), pp. 100973. Date of Electronic Publication: 2020 Dec 15.

Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer.

Autor: Petrioli R; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy. Electronic address: r.petrioli@ao-siena.toscana.it., Torre P; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Pesola G; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Paganini G; General Medicine& Oncology, Pieve di Coriano Hospital, ASST Mantova, Italy., Paolelli L; Medical Oncology, Vito Fazzi Hospital, Lecce, Italy., Miano ST; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Martellucci I; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Francini G; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Francini E; La Sapienza University, Rome, Italy; Medical Oncology Unit, Misericordia Hospital, Grosseto, Italy.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2020 May; Vol. 11 (4), pp. 647-651. Date of Electronic Publication: 2019 Aug 27.